| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |